Рак предстательной железы : литература
Albertson PC et al: Long-term survival among men with conservatively treated localized prostate cancer. JAMA 274:626, 1995
Bagshaw MA External radiation therapy of carcinoma of the prostate. Cancer 45:1912, 1980
Byar DP, Corle DK: VACURG randomized trial of radical prostatectomy for stages I and II prostate cancer. Urology 17(Suppl 4):7, 1981
Catalona WJ: Screening for prostate cancer. JAMA 273:1174, 1995
Catalona WJ, Bigg SW: Nerve-sparing radical prostatectomy: Evaluation of results after 250 patients. J Urol 143:538, 1990
Cooner WH et al: Prostate cancer detection in a clinical urological practice by ultrasonography, digital rectal examination and prostate specific antigen. J Urol 143:1146, 1990
Crawford ED et al: A controlled trial of leuprolide with and without flutamide in prostatic carcinoma. N Engl J Med 321:419, 1989
Eisenberger MA et al: A critical assessment of the role of chemotherapy for endocrine resistant prostatic carcinoma. AUA Update Series Lesson 28, vol 7, 1988
Hennricksson P, Johansson S-E: Prediction of cardiovascular complication in patients with prostatic cancer treated with estrogen. Am J Epidemiol 125:970, 1987
Herr HW: Iodine 125 implantation in the management of localized prostatic carcinoma. Urol Clin North Am 7:605, 1980
Hugosson J et al: Prostate cancer mortality in patients surviving more than 10 years after diagnosis. J Urol 154:2115, 1995
Israeli RS et al: Sensitive detection of prostatic hematogenous tumor celt dissemination using prostate specific antigen and prostate specific membrane-derived primers in the polymerase chain reaction. J Urol 153:573, 1995
Jewett HJ: Radical perineal prostatectomy for palpable clinically localized, non-obstructive cancer: Experience at the Johns Hopkins Hospital, 1909-1963. J Urol 124:492, 1980
Katz A et al: Enhanced reverse transcriptase-polymerase chain reaction for prostate specific antigen as an indicator of true pathologic stage in patients with prostate cancer. Cancer 75:1642, 1995
Laing AH et al: Strontium-89 chloride for pain palliation in prostatic skeletal malignancy. Br J Radiol 64:816, 1991
Morgan TO et al: Age-specific reference ranges for serum prostatespecific antigen in black men. N Engl J Med 336:304, 1996
National Institutes of Health Consensus Development Conference: The management of clinically localized prostate cancer. J Urol 138:1369, 1987
Oesterling JE et al: Free, complexed and total serum prostate specific antigen: The establishment of appropriate reference ranges for their concentrations and ratios. J Urol 154:1090, 1995
Stamey TA, McNeal JE: Adenocarcinoma of the prostate, in Campbell's Urology, 6th ed., PC Walsh et al. (eds). Philadelphia, Saunders, 1992, p 1159
Taplin ME et al: Mutations of the androgen receptor gene in metastatic androgen-independent prostate cancer. N Engl J Med 332:1393, 1995
Tyrrell CJ et al: A multicenter randomized trial comparing the luteinizing hormone-releasing hormone analogue goserelin acetate alone and with flutamide in the treatment of advanced prostate cancer. J Urol 146:1321, 1991
